Description
CJC-1295 is a synthetic analogue of growth hormone releasing hormone (GHRH) designed to increase plasma levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). When modified with DAC (Drug Affinity Complex), the peptide binds to circulating albumin, significantly extending its plasma half-life and allowing for sustained, long-lasting activity.
